Biocon Research Limited, a active public limited company, was established on 28 May 2008 in Bangalore, Karnataka, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U73100KA2008PLC046583. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 536 professional, Its leadership includes Kiran Mazumdar Shaw (Director), John Mccallum Marshall Shaw (Director), Arun Suresh Chandavarkar (Director). Past directors included John Russell Fotheringham Walls, Daniel Mark Bradbury, Harish Venkatachalam Iyer. Its latest AGM occurred on 26 July 2019, with the balance sheet filed on 31 March 2019. It is based at 20Th Km, Hosur Road Electronics City P.O., Bangalore, Karnataka, 560100.
U73100KA2008PLC046583
046583
28 May 2008
₹1.00 M
₹0.50 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Biocon Research Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Mazumdar Shaw | Director | 28 May 2008 | Current |
| John Mccallum Marshall Shaw | Director | 28 May 2008 | Current |
| Arun Suresh Chandavarkar | Director | 28 May 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Oct 2017 | Past |
| Pramod Abcsdd | Director | 26 Oct 2017 | Past |
| Pramod Abcsdd | Director | 23 May 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biocon Research Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 12.79% increase. The company also saw a substantial improvement in profitability, with a 29.23% increase in profit. The company's net worth Soared by an impressive increase of 58.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Biocon Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Biocon Research has a workforce of 536 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Biocon Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocon Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Biocon Research Limited last Annual general meeting of members was held on 26 Jul 2019 as per latest MCA records. was documented.
Progress on Biocon Research Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Bangalore. was documented.
Progress on Kiran Mazumdar Shaw was appointed as a Director was appointed as a Director on 28 May 2008 & has been associated with this company since 17 years 6 months . was documented.
The activity John Mccallum Marshall Shaw was appointed as a Director was appointed as a Director on 28 May 2008 & has been associated with this company since 17 years 6 months . was completed.
Arun Suresh Chandavarkar was appointed as a Director was appointed as a Director on 28 May 2008 & has been associated with this company since 17 years 6 months . was recorded as a recent event.
Biocon Research Limited was registered on 28 May 2008 with Roc Bangalore & aged 17 years 6 months as per MCA records. was recorded as a recent event.
Biocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalmology product for neovascular and age-related macular degeneration, in Canada by July 1, 2025..
Sen was appointed as the CFO of the company in April 2021 after Anupam Jindal stepped down. He has over 20 years of experience in financial planning, treasury, taxation and financial reporting..
The firm had acquired the American pharmaceutical company’s biosimilars business in November 2022..
The CIN of Biocon Research Limited is U73100KA2008PLC046583.
Biocon Research Limited is headquartered at 20Th Km, Hosur Road Electronics City P.O., Bangalore, Karnataka, 560100.
Biocon Research Limited was incorporated on 28 May 2008.
The current directors of Biocon Research Limited are
The primary industry of Biocon Research Limited is Professional, Scientific And Technical.
Biocon Research Limited is unlisted.
The authorized capital of Biocon Research Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Biocon Research Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX